| http://www.w3.org/ns/prov#value | - In some patients, for example, mutations such as M184V or K103N, selected by a previous regimen, were detected only in PBMCs; because these mutations are known to be responsible for resistance to cytidine analogues and to NNRTIs, respectively,29-32 their presence in the reservoirs might further accelerate the emergence of a drug-resistant mutant.
|
